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Illinois EPA Study of 
Pharmaceuticals in Drinking Water
? Looking at raw and finished drinking water at the 
plant before entering the distribution system
? Chicago, Aurora, Elgin, Rock Island, East St. 
Louis
? Rationale for selection:  
Chicago is highest population served 
by surface water
Other surface water supplies are 
relatively close to wastewater discharges
Illinois EPA Study of 
Pharmaceuticals in Drinking Water 
Cont’d
? Substances being analyzed:
Acetaminophen, Amoxicillin, Antipyrine,
Aspirin®, Azithromycin, Bacitracin, 





Chlortetracycline, Ciprofloxacin, Clofibric 
acid, Cotinine, DEET, Diclofenac, 
Dilantin®, Diltiazem, Doxycylcine, 
Enrofloxacin, Erythromycin, 
Fluoxetine/Prozac®, Gemfribozil, 
Ibuprofen, Lasalocid, Oxytetracycline, 
Levothyrozine/Synthroid®, Lincomycin, 
Monensin, Naproxen, Narasin, Nicotine, 
Norfloxacin, Oleandomycin, 
Oxytetracycline, Penicillin G, Penicillin V, 
Prednisone, Roxithromycin, Salinomycin, 
Simvastatin, Sulfachloropyridazine, 
Sulfadiazine, 
Illinois EPA Study of 
Pharmaceuticals in Drinking Water 
Cont’d
Illinois EPA Study of 




Sulfathiazole, Triclosan, Trimethoprim, 
Tylosin, Virginiamycin M1, 
? Analytical results expected this week; 
toxicological evaluation by IEPA and 
IDPH.

Potential Approaches for Developing 
“MCLs” for Pharmaceuticals
? Prescribed dose approach
• Prescribed dose as LOEL for side effects
• UF = 1,3, or 10 for:
· LOEL to NOEL
· Extrapolation to chronic exposure
· Human Variability
· Extrapolation from animal to humans
• Convert “reference dose” to “MCL”
MCL = (FRD x BW/1R) X RSC
Potential Approaches for Developing 
“MCLs” for Pharmaceuticals Cont’d
?Maximum recommended therapeutic dose 
approach
• Same approach as above
• Only human data in MRTD database, 
1309 chemicals
? Evaluate additive effects with either 
approach
